Ignite Creation Date:
2025-12-26 @ 12:14 PM
Ignite Modification Date:
2025-12-31 @ 2:32 PM
Study NCT ID:
NCT00299000
Status:
COMPLETED
Last Update Posted:
2011-07-22
First Post:
2006-03-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI
Sponsor:
BioMarin Pharmaceutical
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-05
Start Date Type:
None
Primary Completion Date:
2009-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-04
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-02
First Submit QC Date:
None
Study First Post Date:
2006-03-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-05-07
Results First Submit QC Date:
None
Results First Post Date:
2010-10-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-07-19
Last Update Post Date:
2011-07-22
Last Update Post Date Type:
ESTIMATED